CN107951527A - A kind of surgical operation wrapping tourniquet - Google Patents
A kind of surgical operation wrapping tourniquet Download PDFInfo
- Publication number
- CN107951527A CN107951527A CN201711469692.4A CN201711469692A CN107951527A CN 107951527 A CN107951527 A CN 107951527A CN 201711469692 A CN201711469692 A CN 201711469692A CN 107951527 A CN107951527 A CN 107951527A
- Authority
- CN
- China
- Prior art keywords
- wrapping
- tourniquet
- closeer
- fiber
- surgical operation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000000835 fiber Substances 0.000 claims abstract description 72
- 210000004369 blood Anatomy 0.000 claims abstract description 48
- 239000008280 blood Substances 0.000 claims abstract description 48
- 230000023597 hemostasis Effects 0.000 claims abstract description 48
- 229920000742 Cotton Polymers 0.000 claims abstract description 30
- 239000000463 material Substances 0.000 claims abstract description 30
- 230000002344 fibroplastic effect Effects 0.000 claims abstract description 3
- 235000015849 Apium graveolens Dulce Group Nutrition 0.000 claims description 13
- 235000010591 Appio Nutrition 0.000 claims description 13
- 229920003043 Cellulose fiber Polymers 0.000 claims description 13
- 239000000203 mixture Substances 0.000 claims description 11
- 229920001971 elastomer Polymers 0.000 claims description 10
- 229920002522 Wood fibre Polymers 0.000 claims description 9
- 229920000728 polyester Polymers 0.000 claims description 7
- 241001313855 Bletilla Species 0.000 claims description 6
- 241000219357 Cactaceae Species 0.000 claims description 6
- 238000009941 weaving Methods 0.000 claims description 6
- 244000101724 Apium graveolens Dulce Group Species 0.000 claims 1
- 150000002085 enols Chemical class 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 18
- 230000000202 analgesic effect Effects 0.000 abstract description 7
- 238000005516 engineering process Methods 0.000 abstract description 6
- 230000008092 positive effect Effects 0.000 abstract description 4
- 230000000844 anti-bacterial effect Effects 0.000 abstract description 3
- 239000002260 anti-inflammatory agent Substances 0.000 abstract description 3
- 230000001741 anti-phlogistic effect Effects 0.000 abstract description 3
- 239000002874 hemostatic agent Substances 0.000 abstract description 3
- 206010052428 Wound Diseases 0.000 description 21
- 208000027418 Wounds and injury Diseases 0.000 description 21
- 208000032843 Hemorrhage Diseases 0.000 description 18
- 230000000740 bleeding effect Effects 0.000 description 17
- 239000000843 powder Substances 0.000 description 14
- 240000007087 Apium graveolens Species 0.000 description 12
- 239000003814 drug Substances 0.000 description 12
- 241000125175 Angelica Species 0.000 description 11
- 235000001287 Guettarda speciosa Nutrition 0.000 description 11
- 239000004372 Polyvinyl alcohol Substances 0.000 description 10
- 229920002451 polyvinyl alcohol Polymers 0.000 description 10
- 230000001954 sterilising effect Effects 0.000 description 9
- 238000004659 sterilization and disinfection Methods 0.000 description 9
- 230000035876 healing Effects 0.000 description 8
- 230000036592 analgesia Effects 0.000 description 7
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N coumarin Chemical compound C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 7
- 238000000034 method Methods 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- PQMOXTJVIYEOQL-UHFFFAOYSA-N Cumarin Natural products CC(C)=CCC1=C(O)C(C(=O)C(C)CC)=C(O)C2=C1OC(=O)C=C2CCC PQMOXTJVIYEOQL-UHFFFAOYSA-N 0.000 description 6
- FSOGIJPGPZWNGO-UHFFFAOYSA-N Meomammein Natural products CCC(C)C(=O)C1=C(O)C(CC=C(C)C)=C(O)C2=C1OC(=O)C=C2CCC FSOGIJPGPZWNGO-UHFFFAOYSA-N 0.000 description 6
- 240000007673 Origanum vulgare Species 0.000 description 6
- 235000004383 Origanum vulgare subsp. vulgare Nutrition 0.000 description 6
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 6
- 239000006260 foam Substances 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 239000011230 binding agent Substances 0.000 description 5
- 230000006835 compression Effects 0.000 description 5
- 238000007906 compression Methods 0.000 description 5
- 238000013461 design Methods 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 238000003756 stirring Methods 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 description 4
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 description 4
- 235000007650 Aralia spinosa Nutrition 0.000 description 4
- 241000132536 Cirsium Species 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- 241000949456 Zanthoxylum Species 0.000 description 4
- 230000003110 anti-inflammatory effect Effects 0.000 description 4
- 230000023555 blood coagulation Effects 0.000 description 4
- 229940116229 borneol Drugs 0.000 description 4
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 description 4
- 239000002657 fibrous material Substances 0.000 description 4
- 230000002401 inhibitory effect Effects 0.000 description 4
- 239000002245 particle Substances 0.000 description 4
- -1 saccharide compound Chemical class 0.000 description 4
- 239000000341 volatile oil Substances 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 3
- 208000033809 Suppuration Diseases 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 239000006071 cream Substances 0.000 description 3
- 239000006185 dispersion Substances 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 238000001356 surgical procedure Methods 0.000 description 3
- 230000029663 wound healing Effects 0.000 description 3
- HFDVRLIODXPAHB-UHFFFAOYSA-N 1-tetradecene Chemical compound CCCCCCCCCCCCC=C HFDVRLIODXPAHB-UHFFFAOYSA-N 0.000 description 2
- 241000193830 Bacillus <bacterium> Species 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 102000009123 Fibrin Human genes 0.000 description 2
- 108010073385 Fibrin Proteins 0.000 description 2
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 241000533950 Leucojum Species 0.000 description 2
- 229920001410 Microfiber Polymers 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- URLKBWYHVLBVBO-UHFFFAOYSA-N Para-Xylene Chemical group CC1=CC=C(C)C=C1 URLKBWYHVLBVBO-UHFFFAOYSA-N 0.000 description 2
- 241000130764 Tinea Species 0.000 description 2
- 208000002474 Tinea Diseases 0.000 description 2
- 230000000146 antalgic effect Effects 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 229930007927 cymene Natural products 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 239000004744 fabric Substances 0.000 description 2
- 229950003499 fibrin Drugs 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000002008 hemorrhagic effect Effects 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 238000009940 knitting Methods 0.000 description 2
- WFWNFBYXZQJMFM-UHFFFAOYSA-N methylcyclodecane Chemical compound CC1CCCCCCCCC1 WFWNFBYXZQJMFM-UHFFFAOYSA-N 0.000 description 2
- 239000003658 microfiber Substances 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- DTLFSMAJSOYMCO-UHFFFAOYSA-N nonylcyclopropane Chemical compound CCCCCCCCCC1CC1 DTLFSMAJSOYMCO-UHFFFAOYSA-N 0.000 description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
- 230000001590 oxidative effect Effects 0.000 description 2
- HFPZCAJZSCWRBC-UHFFFAOYSA-N p-cymene Chemical compound CC(C)C1=CC=C(C)C=C1 HFPZCAJZSCWRBC-UHFFFAOYSA-N 0.000 description 2
- 239000008188 pellet Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 231100000241 scar Toxicity 0.000 description 2
- MGSRCZKZVOBKFT-UHFFFAOYSA-N thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 230000008733 trauma Effects 0.000 description 2
- 239000000052 vinegar Substances 0.000 description 2
- 235000021419 vinegar Nutrition 0.000 description 2
- SPCXZDDGSGTVAW-HVTMNAMFSA-N (+)-alpha-gurjunene Chemical compound C[C@H]1CC[C@@H]2C(C)(C)[C@@H]2C2=C(C)CC[C@@H]12 SPCXZDDGSGTVAW-HVTMNAMFSA-N 0.000 description 1
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 1
- WWRCMNKATXZARA-UHFFFAOYSA-N 1-Isopropyl-2-methylbenzene Chemical compound CC(C)C1=CC=CC=C1C WWRCMNKATXZARA-UHFFFAOYSA-N 0.000 description 1
- HBOQXIRUPVQLKX-UHFFFAOYSA-N 2,3-di(octadeca-9,12-dienoyloxy)propyl octadeca-9,12-dienoate Chemical compound CCCCCC=CCC=CCCCCCCCC(=O)OCC(OC(=O)CCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC HBOQXIRUPVQLKX-UHFFFAOYSA-N 0.000 description 1
- 241000219317 Amaranthaceae Species 0.000 description 1
- 241000213006 Angelica dahurica Species 0.000 description 1
- 241000167854 Bourreria succulenta Species 0.000 description 1
- 240000005209 Canarium indicum Species 0.000 description 1
- 244000080208 Canella winterana Species 0.000 description 1
- 235000008499 Canella winterana Nutrition 0.000 description 1
- 235000011305 Capsella bursa pastoris Nutrition 0.000 description 1
- 240000008867 Capsella bursa-pastoris Species 0.000 description 1
- 241000219312 Chenopodium Species 0.000 description 1
- 208000032544 Cicatrix Diseases 0.000 description 1
- 235000006481 Colocasia esculenta Nutrition 0.000 description 1
- 244000205754 Colocasia esculenta Species 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 102000008946 Fibrinogen Human genes 0.000 description 1
- 108010049003 Fibrinogen Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 238000012404 In vitro experiment Methods 0.000 description 1
- 244000179970 Monarda didyma Species 0.000 description 1
- 235000010672 Monarda didyma Nutrition 0.000 description 1
- 208000004221 Multiple Trauma Diseases 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 241000187479 Mycobacterium tuberculosis Species 0.000 description 1
- 208000005141 Otitis Diseases 0.000 description 1
- 240000003731 Piper cubeba Species 0.000 description 1
- 235000002711 Piper cubeba Nutrition 0.000 description 1
- 241000588769 Proteus <enterobacteria> Species 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 241000208422 Rhododendron Species 0.000 description 1
- 235000004443 Ricinus communis Nutrition 0.000 description 1
- 241000607764 Shigella dysenteriae Species 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- DLCJNIBLOSKIQW-UHFFFAOYSA-N Sphondin Chemical compound C1=CC(=O)OC2=C1C=C(OC)C1=C2C=CO1 DLCJNIBLOSKIQW-UHFFFAOYSA-N 0.000 description 1
- RJTWNFGVXRAFBF-UHFFFAOYSA-N Sphondin Natural products C1CC(=O)OC2=C1C=C(OC)C1=C2C=CO1 RJTWNFGVXRAFBF-UHFFFAOYSA-N 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 208000002847 Surgical Wound Diseases 0.000 description 1
- 239000005844 Thymol Substances 0.000 description 1
- 208000037386 Typhoid Diseases 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 125000003158 alcohol group Chemical group 0.000 description 1
- 150000001336 alkenes Chemical class 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000004760 aramid Substances 0.000 description 1
- 229920003235 aromatic polyamide Polymers 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- WDIHJSXYQDMJHN-UHFFFAOYSA-L barium chloride Chemical compound [Cl-].[Cl-].[Ba+2] WDIHJSXYQDMJHN-UHFFFAOYSA-L 0.000 description 1
- 229910001626 barium chloride Inorganic materials 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000000157 blood function Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- HHTWOMMSBMNRKP-UHFFFAOYSA-N carvacrol Natural products CC(=C)C1=CC=C(C)C(O)=C1 HHTWOMMSBMNRKP-UHFFFAOYSA-N 0.000 description 1
- RECUKUPTGUEGMW-UHFFFAOYSA-N carvacrol Chemical compound CC(C)C1=CC=C(C)C(O)=C1 RECUKUPTGUEGMW-UHFFFAOYSA-N 0.000 description 1
- 235000007746 carvacrol Nutrition 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 235000019693 cherries Nutrition 0.000 description 1
- ALSTYHKOOCGGFT-UHFFFAOYSA-N cis-oleyl alcohol Natural products CCCCCCCCC=CCCCCCCCCO ALSTYHKOOCGGFT-UHFFFAOYSA-N 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 239000003218 coronary vasodilator agent Substances 0.000 description 1
- 235000001671 coumarin Nutrition 0.000 description 1
- 150000004775 coumarins Chemical class 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- NEKNNCABDXGBEN-UHFFFAOYSA-L disodium;4-(4-chloro-2-methylphenoxy)butanoate;4-(2,4-dichlorophenoxy)butanoate Chemical class [Na+].[Na+].CC1=CC(Cl)=CC=C1OCCCC([O-])=O.[O-]C(=O)CCCOC1=CC=C(Cl)C=C1Cl NEKNNCABDXGBEN-UHFFFAOYSA-L 0.000 description 1
- POULHZVOKOAJMA-UHFFFAOYSA-M dodecanoate Chemical compound CCCCCCCCCCCC([O-])=O POULHZVOKOAJMA-UHFFFAOYSA-M 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 239000004862 elemi Substances 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 239000003822 epoxy resin Substances 0.000 description 1
- 229940011871 estrogen Drugs 0.000 description 1
- 239000000262 estrogen Substances 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 229940012952 fibrinogen Drugs 0.000 description 1
- 238000003304 gavage Methods 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229930010848 gurjunene Natural products 0.000 description 1
- 238000001631 haemodialysis Methods 0.000 description 1
- 230000002439 hemostatic effect Effects 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- 210000003405 ileum Anatomy 0.000 description 1
- 230000003116 impacting effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- WYXXLXHHWYNKJF-UHFFFAOYSA-N isocarvacrol Natural products CC(C)C1=CC=C(O)C(C)=C1 WYXXLXHHWYNKJF-UHFFFAOYSA-N 0.000 description 1
- RWGFKTVRMDUZSP-UHFFFAOYSA-N isopropyl-benzene Natural products CC(C)C1=CC=CC=C1 RWGFKTVRMDUZSP-UHFFFAOYSA-N 0.000 description 1
- 229940070765 laurate Drugs 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 230000036407 pain Effects 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 229920000647 polyepoxide Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 1
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
- 238000004080 punching Methods 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 230000037387 scars Effects 0.000 description 1
- 229940007046 shigella dysenteriae Drugs 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 230000008925 spontaneous activity Effects 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 238000001256 steam distillation Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 230000009182 swimming Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- 229940095068 tetradecene Drugs 0.000 description 1
- 229960000790 thymol Drugs 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 201000008297 typhoid fever Diseases 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 239000005526 vasoconstrictor agent Substances 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/12—Surgical instruments, devices or methods for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels or umbilical cord
- A61B17/132—Tourniquets
- A61B17/1322—Tourniquets comprising a flexible encircling member
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/00051—Accessories for dressings
- A61F13/00063—Accessories for dressings comprising medicaments or additives, e.g. odor control, PH control, debriding, antimicrobic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/01—Non-adhesive bandages or dressings
- A61F13/01008—Non-adhesive bandages or dressings characterised by the material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/02—Adhesive bandages or dressings
- A61F13/0203—Adhesive bandages or dressings with fluid retention members
- A61F13/0206—Adhesive bandages or dressings with fluid retention members with absorbent fibrous layers, e.g. woven or non-woven absorbent pads or island dressings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/40—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing ingredients of undetermined constitution or reaction products thereof, e.g. plant or animal extracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/44—Medicaments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M35/00—Devices for applying media, e.g. remedies, on the human body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/12—Surgical instruments, devices or methods for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels or umbilical cord
- A61B2017/12004—Surgical instruments, devices or methods for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels or umbilical cord for haemostasis, for prevention of bleeding
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/30—Compounds of undetermined constitution extracted from natural sources, e.g. Aloe Vera
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Vascular Medicine (AREA)
- Hematology (AREA)
- Epidemiology (AREA)
- Materials Engineering (AREA)
- Surgery (AREA)
- Reproductive Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Botany (AREA)
- Zoology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Anesthesiology (AREA)
- Materials For Medical Uses (AREA)
Abstract
The present invention relates to a kind of binding hemostat of field of medical technology, specific features are：The device possesses the wrapping tourniquet mesh skeleton of cotton fiber, with adhere in the inside of the surface side of sucking blood of the wrapping tourniquet mesh skeleton or from surface to inside elastic bar and the closeer fibroplastic closeer fibrous layer thinner by the fiber than wrapping up tourniquet mesh skeleton being affixed with wound, hemostasis rehabilitation material is fixed with closeer fibrous layer, the surgical operation is quick obvious with wrapping tourniquet wrapping hemostasis, medicinal material curative effect protrudes, it is good to wound bactericidal antiphlogistic analgesic specific aim, Rehabilitation positive effect, have been widely used in medical field especially surgical operation wrapping field tool.
Description
Technical field
The present invention relates to field of medical technology, more particularly relates to a kind of binding hemostat.
Background technology
When arteriorrhexis caused by operation or wound, blood flow is flowed out in cherry spurting, and blood loss is more, harmfulness
Greatly, if not stopping blooding immediately, threat to life, when bleeding occurs, fibrinogen forms fiber egg with water and blood coagulation enzyme reaction
In vain, the fibrin insoluble in blood and polymerize to form clot, and bleeding is by suturing or closing in surgical procedures
Notch or internal hemorrhagic areas solve, and by using cotton or other are used to apply pressure or absorption for bleeding site
The material of blood solves.However, when the bleeding becomes excessive, these measures may be not enough to rapidly make to bleed on demand to stop
Only, once these hemostatic foams, which are saturated with blood, will lose compression strength, this almost carry out the foam after use
Operation, in addition existing cloth material the shortcomings that be a lack of elasticity can not be to the elastic compression of bleeding position continuous and effective, and it stops
Blood characteristic is that these foams cannot quickly absorb aqueous solution dependent on the shortcomings that fibrin ferment foam present in foam, since it is
Airproof compact texture, wraps up bleeding part and is also possible to cause suppuration to be rotted, the presence of problem above is to patient's for a long time
Medical rehabilitation, which exists, to be seriously affected.
The content of the invention
Present invention employs a kind of surgical operation wrapping of rational structure and material design to solve the above-mentioned problems
Tourniquet, is specially：A kind of surgical operation wrapping tourniquet, it is characterised in that the wrapping tourniquet for possessing cotton fiber is netted
Skeleton and the inside of the surface side of sucking blood of the wrapping tourniquet mesh skeleton or adhere to from surface to inside elastic bar and
It is fixed in closeer fibrous layer by the thinner closeer fibroplastic closeer fibrous layer of the fiber than wrapping up tourniquet mesh skeleton
Equipped with hemostasis rehabilitation material.
Further, the average fiber length of the closeer fiber is 0.02~4mm.
Further, the average fiber length of the closeer fiber is relative to ratio, that is, draw ratio of avarage fiber diameter
900~9000.
Further, the closeer fiber is by selected from by wood fibre, polyester fiber, foamed cotton, cellulose fibre, regeneration
At least one of sponge, rubber cotton form.
Further, adhesion amount of the closeer fiber on the wrapping tourniquet mesh skeleton is 0.1~10g/
m2。
Further, the wrapping tourniquet mesh skeleton is weaving cotton rope.
Further, the wrapping tourniquet mesh skeleton is by selected from by wood fibre, polyester fiber, foamed cotton, fiber
At least one of group of cellulose fiber, renewable sponge, rubber cotton and polyvinyl alcohol composition and formed.
Further, the closeer fibrous layer contains hemostasis rehabilitation material and includes at least in gallop along on horseback celery, bletilla, cactus
It is a kind of.
The beneficial effects of the invention are as follows the elastic bar and closeer fiber designed on the mesh skeleton by cotton fiber material
Layer overall structure, realizes and quickly sucks blood, and mesh skeleton can be tightened by being shunk after being wrapped up again after balance of sucking blood by elastic bar,
Further conductance makes closeer fibrous layer stop blooding closer to closeer fitting and elastic compression blutpunkte successively after mesh skeleton tightening,
Due to being fixed with the Chinese herbal medicine powder particle of hemostasis sterilization analgesia healing of wound in closeer fibrous layer, which on the one hand can be with
Hemostasis blood coagulation is played, the medicine effect for treating of anti-inflammation and sterilization analgesic, the another aspect pellet design is in closeer fibrous layer so that hemostasis
Band will not shut overall structure after tightening can be with conduct air so that suppuration of rotting does not occur for wound outermost layer；Due to the hemostasis
Recuperating medicine granule material be fixedly installed in closeer fibrous layer the therefore particle will not be dissolved into blood or come off spread it is ineffective；
Make it that the absorption of blood is quick and will not be swollen due to the use of above-mentioned fibrous material, and the design of material is safe to the human body
Have no toxic side effect, in conclusion the surgical operation is quick obvious with wrapping tourniquet wrapping hemostasis, medicinal material curative effect protrudes, to wound
Mouth bactericidal antiphlogistic analgesic specific aim is good, Rehabilitation positive effect, has in medical field especially surgical operation wrapping field wide
General purposes.
Brief description of the drawings
Attached drawing described herein is used for providing a further understanding of the present invention, forms the part of the present invention, this hair
Bright schematic description and description is used to explain the present invention, does not form inappropriate limitation of the present invention.In the accompanying drawings：
Fig. 1 wraps up tourniquet partial schematic diagram for currently preferred surgical operation
Fig. 2 is to represent the schematic cross sectional view that the A-A directions section view in Fig. 1 is formed
Fig. 3 is the schematic diagram for illustrating the process of sucking blood that tourniquet is wrapped up using the surgical operation shown in Fig. 2
Fig. 4 is the sectional view for being schematically illustrated at the state stopped blooding on the surgical operation wrapping tourniquet shown in Fig. 2.
Embodiment
Carry out the preferred embodiment that the present invention will be described in detail below in conjunction with schema and embodiment, thereby to the present invention how
Application technology means solve technical problem and reach the process of realizing of technical effect to fully understand and according to this implement.
Referring to the drawings come illustrate the present invention surgical operation with wrapping tourniquet preferred embodiment.
As shown in Figure 1 and Figure 2, the surgical operation wrapping tourniquet 1 of present embodiment is the wrapping hemostasis in cotton fiber
Face 10a sides of sucking blood with mesh skeleton 10 possess by the thinner closeer fiber 21 of the fiber than wrapping up tourniquet mesh skeleton 10
The closeer fibrous layer 20 formed.
Wrapping tourniquet mesh skeleton 10 is formed by weaving cotton rope, the cloth-like material for knitting the cotton fibers such as line.In this embodiment party
In formula, as filter cloth mesh skeleton 10, using possess elastic bar 11 contribute to compression hemostasis and the healing of wound to wound,
With in the both sides of elastic bar 11 with the close weaving cotton rope for knitting the stratum reticulare 12 to be formed.From compress property, anti-hemostat deciduous, thoroughly
From the viewpoint of gas and cost, the material that 10 preferred basis weights of tourniquet mesh skeleton are 400~600g/m2 is wrapped up.Separately
Outside, the material that fibre diameter is several μm~tens of μm can be used.
As wrapping tourniquet mesh skeleton 10, the thickness that can use such as elastic bar 11 is about 0.2mm, stratum reticulare
Elastic bar of 12 thickness in one side about 2.0mm.It should be noted that weaving cotton rope bumps with knit line compared with are small, can be with
Closeer fibrous layer 20 is generally formed uniformly on surface, therefore preferably using weaving cotton rope as wrapping tourniquet mesh skeleton
10。
As the material of wrapping tourniquet mesh skeleton 10, can use by selected from by wood fibre, polyester fiber, hair
Foam, cellulose fibre, renewable sponge, rubber cotton and polyvinyl alcohol composition at least one of group fiber and the thing that is formed
Matter.For example, in the case where requiring flexibility, preferably using by selected from by wood fibre, cellulose fibre, renewable sponge, rubber
At least one of the group fiber of collodion and polyvinyl alcohol composition and the wrapping tourniquet mesh skeleton 10 formed.In addition, wanting
In the case of seeking oxidative resistance, preferably using by selected from being made of cellulose fibre, renewable sponge, rubber cotton and polyvinyl alcohol
At least one of group fiber and the wrapping tourniquet mesh skeleton 10 that is formed.Moreover, in the case where requiring adhesiveness, preferably
Using by selected from least one of group being made of wood fibre, foamed cotton, cellulose fibre, renewable sponge and polyvinyl alcohol
Fiber and the wrapping tourniquet mesh skeleton 10 formed.In addition, in the requirement height impacting of flexibility, chemical proofing etc.
In the case of, in terms of cost etc., preferably using the wrapping tourniquet mesh skeleton 10 formed by polyester fiber.
Closeer fibrous layer 20 being internally formed from the face 10a that sucks blood to wrapping tourniquet mesh skeleton 10.In closeer fiber
Layer 20 in be fixed with can stop blooding, sterilize, the hemostasis rehabilitation agent of anti-inflammatory rehabilitation wound.It should be noted that closeer fibrous layer 20
It can also be formed in the inside (inside stratum reticulare 12) of the face 10a sides of sucking blood of wrapping tourniquet mesh skeleton 10.Closeer fiber
Layer 20 has than the thinner network structure of wrapping tourniquet mesh skeleton 10, plays a part of surface and sucks blood compacting.Herein, originally
" the microfibre layer " of invention refers to that closeer fiber 21 is formed as the layer of stratiform with stratum reticulare 12 with interweaving, and is not limited to same
Thickness is formed as the layer of stratiform, as long as be formed continuously from face 10a sides of sucking blood very close to each otherly.
In the present embodiment, as closeer fiber 21, preferably using selected from by wood fibre, polyester fiber, foamed cotton,
At least one of the group that cellulose fibre, renewable sponge, rubber cotton and polyvinyl alcohol form fiber.For example, requiring softness
In the case of property, preferably using by selected from being made of wood fibre, cellulose fibre, renewable sponge, rubber cotton and polyvinyl alcohol
At least one of group fiber and the closeer fiber 21 that is formed.In addition, in the case where requiring oxidative resistance, preferably using by
Selected from least one of the group being made of cellulose fibre, renewable sponge, rubber cotton and polyvinyl alcohol fiber formed compared with
Close fiber 21.Moreover, in the case where requiring adhesiveness, preferably using by selected from by aromatic polyamides, foamed cotton, cellulose fiber
Dimension, renewable sponge and polyvinyl alcohol composition at least one of group fiber and the closeer fiber 21 that is formed.Especially, except above-mentioned
Beyond characteristic, from processing easness, be not easy it is powered, consider in price etc., it is closeer preferably using being formed by cellulose fibre
Fiber 21.
The average fiber length of closeer fiber 21 is preferably 0.01~5mm.For the closeer fibre of this fibre length
Dimension, it is easy to manufacture and cost can be suppressed.In addition, by the way that fibre length is set as more than 0.01mm, closeer fiber easily exists
On stratum reticulare 12 fully fixed (intertextures), by the way that fibre length is set as below 5mm, disperse in dispersion liquid during manufacture
Property, the uniformity of closeer fibrous layer 20 improve.
In addition, the average fiber length of closeer fiber 21 relative to avarage fiber diameter ratio (average fiber length/
Avarage fiber diameter：Draw ratio) it is preferably 1000~10000.As closeer fiber 21, although with nano level average
Diameter (such as 1nm~5000nm, more preferably 10nm~hundreds of nm), but preferably using the fine of longer fibre length
Fiber.By using such closeer fiber 21, closeer fiber 21 is imported into inside stratum reticulare 12, and make closeer fiber 21
Interweave and easily form closeer fibrous layer 20, can be by pressure conduction and hemostasis efficiency control in appropriate condition.
In order to make closeer fibrous layer 20 obtain the characteristic that raising hemostasis efficiency and increase pressure conduction are difficult to take into account, preferably
The weight per unit area (adhesion amount) of closeer fiber 21 is set as 0.1~10g/m2.
By adhering to the closeer fiber 21 of more than 0.1g/m2, due in order to play the role of surface suck blood compacting and can
An adequate amount of closeer fibrous layer 20, therefore the hemostasis efficiency that can be improved are formed, is improved particularly less than 5 μm of hemostasis efficiency.
In addition, by the way that the adhesion amount of closeer fiber 21 is set as below 10g/m2, pressure conduction can be increased, in addition,
Suck blood since adhesion amount is not excessive with the flexibility of appropriateness, easily hemostasis.
In addition, the value of the quality factor used from the performance indicator as hemostasis of sucking blood considers, more preferably 1~
The scope of 5g/m2.
With said structure surgical operation wrapping tourniquet 1 for example, can by from wrapping tourniquet mesh skeleton
10 single-face side is penetrated into stratum reticulare 12 come shape using the dispersion liquid that spraying, coating, impregnating make to be dispersed with closeer fiber 21
Into.Herein, in order to make closeer fiber 21 be securely fixed in stratum reticulare 12, and hemostasis rehabilitation agent is made to be not easy to be dissolved in water punching
Wash off, polyvinyl alcohol, the epoxy resin of 0.01 parts by weight or so can also be added relative to microfibre 21 into dispersion liquid
Deng compound binders such as organic binder bond, or the saccharide compound such as plant macromolecule, clays.
Hereinafter, to being said using the surgical operation of described above with wrapping tourniquet 1 to inhale the method only bled profusely
It is bright.In order to remove bleeding with wrapping tourniquet 1 by the surgical operation of present embodiment, so that the face 10a that sucks blood is upper
Surgical operation wrapping tourniquet 1 is placed in surgical operation by the mode for swimming side.When starting surgical operation, as shown in figure 3, side
Just the blood containing D is affixed from face 10a sides of sucking blood and wrap up tourniquet 1 using surgical operation.
At this time, as shown in figure 4, closeer fibrous layer 20 plays a part of surface sucks blood compacting, D is inhaled by closeer fibrous layer 20
Blood.In surgical operation uses wrapping tourniquet 1, since closeer fibrous layer 20 is only relatively thinly formed in face 10a sides of sucking blood, because
This can reduce pressure conduction.Further, since it is small compared with the fine pore of close fibrous layer 20, therefore can improve with existing wrapping
Tourniquet be difficult to maintain it is sucking blood while low-pressure conduction, less than 5 μm, especially 1~3 μm or so of hemostasis imitates
Rate.Improved hemostasis efficiency it can improve the characteristic for being improved with pressure conduction and being difficult to take into account together.
The usage of the classification to bleeding and the tourniquet is further described below：According to existing clinical case,
Following a few classes can be roughly divided into：Exterior trauma is sucked blood hemostasis, and wound healing exudation haemodialysis, surgical procedures medium vessels goes out
Blood.
When tourniquet is sucked blood under hemostasis used in exterior trauma, its application method first choice is chosen according to face bleeding
The tourniquet of size reasonable is affixed bleeding part with closeer fibrous layer in the case of non-tighten and sucks blood, and then carries out being stopped blooding with this
Band carries out wrapping hemostasis, and hemostasis rehabilitation material is fixed with the closeer fibrous layer of tourniquet and helps quick realization normal solidifying
Blood function, when massive haemorrhage occurs, then can occur excessive blood loss or when bleeding is severe, the Ying Shili closeer fibre of the tourniquet
Dimension layer is affixed bleeding part and wraps up immediately, firmly timely mode can be stopped and bled using the distinctive conducting pressure of the tourniquet
.
When tourniquet is used in wound outflow blood or diffusate, its application method first choice is chosen according to face bleeding
The tourniquet of size reasonable, then carries out being affixed bleeding part with the closeer fibrous layer of the tourniquet and is wrapped up, the tourniquet
Hemostasis rehabilitation material is fixed with closeer fibrous layer, the part in the hemostasis rehabilitation material can be dissolved in the blood from wound
Or diffusate, so as to potentially make only rehabilitation blood agent play effect.
The bleeding in surgical procedures is in use, bleeding comes sometimes through suture or close incisions or internal hemorrhagic areas
Solve, and pressure is applied for bleeding site by using tourniquet in the present invention and absorbs solving for blood.When going out
When blood becomes excessive, reusable only tourniquet is sucked blood, or is applied as needed repeatedly and for reducing wound healing
Time required any duration.
Blood band of the present invention contributes to by removing diffusate or blood and/or helping blood clotting come the wound that heals
Mouthful.In some medical schemes, reducing the method for wound healing time also includes by tourniquet to wound surface, makes wound
Remove scar or cell formation.
In some medical cases, tourniquet according to the present invention is used to the duration root of about hour of wound
Disabled according to effect；In some cases, the tourniquet is reused immediately or after a period of time.In some cases, use
The tourniquet is removed after duration when the tourniquet at least about 24 is small and is positioned over clean tourniquet other required
The position wanted.
Further, the hemostasis rehabilitation material that is fixed with closeer fibrous layer is：Can hemostasis, sterilization, anti-inflammatory health
The hemostasis rehabilitation medicament of multiple wound, medicament composition are as follows：Gallop along on horseback celery 5-9g, wild marjoram 1-3g, spinyleaf pricklyash root 6-8g cactus 3-5g,
Setose thistle 2-3g, bletilla 3-5g, borneol 2-3g, is ground into powder, adds silty snowflake 500-1500g, stirs into medicinal powder.
Hereafter component physicochemical property in hemostasis rehabilitation material and efficacy experiment are described in detail, celery of galloping along on horseback is called white
The root of Dahurian angelica, the chemical composition in relation to celery of galloping along on horseback contain a variety of active ingredients, oneself separates from celery of galloping along on horseback at present identifies about more than 10 and plant
Cumarin, these cumarins majority have stronger bioactivity, it is broadly divided into three classes:The first kind, simple Coumarins, bag
Include umbrella shape and spend interior cruel, the second class, predominantly bark mutter ring and cumarin parent nucleus it is different collect cumularsharoliths and connect the angle-style to be formed bark perfume (or spice) of muttering
Legumin class, there is a sphondin, cruel in different bergamot, mattress celery cumarin, another kind of to be one and reflect ring of muttering with cumarin parent nucleus 6,7
The straight type that position connection is formed, which is barked, mutters cumarin as different mattress celery cumarin etc., using mono- Ms technologies of Gc to volatile oil component in Radix angelicae dahuricae
Studied, isolated 62 components, and wherein 23 kinds are identified, identify that component accounts for volatile oil gross weight
85%. wherein with nonyl cyclopropane, a- trips alkene, ten four carbon alcohols contents are higher, methyl cyclodecane, tetradecene, laurate second
Vinegar, oleic alcohol, single linolein, vinegar in ring 15, octadecanol, elemi, based on gurjunene.Other compositions find to gallop along on horseback first
6 chemical compositions such as succinic acid, glucose, sucrose in the water soluble ingredient of celery.Gallop along on horseback celery（The root of Dahurain angelica）There is as follows, solution
Heat, analgesia, anti-inflammatory, effect are respectively provided with antipyretic-antalgic and anti-inflammatory effect, its antalgic and inflammation relieving component is in fat-soluble position, root of Dahurain angelica decocting liquid
15g gavages have obvious antipyretic effect to albumen arteries and veins induced mice High fever model is subcutaneously injected, its 4g decocting liquid paraxylene
Induced mice ear inflammation also significantly inhibits effect, and the analgesic activity of the root of Dahurain angelica is not notable to the ca concentration of Mouse Inferior Collicular brain area
Influence, experiment shows the analgesic activity of the root of Dahurain angelica and the effect of resisting pathogenic microbes, and the root of Dahurain angelica has various bacteria inhibitory action, in vitro
Experiment shows that root of Dahurain angelica decoction is to Escherichia coli, shigella dysenteriae, proteus, typhoid bacillus, Pseudomonas aeruginosa, Bacillus tuberculosis
Deng there is inhibitory action, for root of Dahurain angelica water decoction also to paratyphoid, comma bacillus has certain inhibitory action, and flooding agent is to Epidermophvton
The pathomycetes such as the hidden tinea bacterium of tinea bacterium, budlet also have certain inhibitory action, the effect to cardiovascular, blood and smooth muscle, root of Dahurain angelica element
There is dilating effect to coronary vasodilator, and the water soluble ingredient of the root of Dahurain angelica has vasoconstrictor effects, capillary tube method experiment shows the root of Dahurain angelica
Water soluble ingredient has anastalsis, if to having solution in body or isolated rat uterus spasm caused by eastern castor element, estrogen or barium chloride
Convulsion acts on, and the ether soluble components of the root of Dahurain angelica and Radix angelicae dahuricae can suppress isolated small intestines of rabbits spontaneous activity, have significantly to rabbit ileum
Spasmolysis.Wild marjoram is called P-cymene, its entitled 1- methyl -4- cumene of chemistry, also known as cymene, is terpene
Compound, is the parent of carvacrol and Thymol to P-cymene, and is also volatile oil as them, colourless to have aroma
Taste.177.10 DEG C of boiling point, -67.94 DEG C of fusing point, 20 DEG C of density are 0.8573g/cm3；25 DEG C are 0.8533g/cm3.Refractive index
1.4909、1.4885；It is not soluble in water, can be miscible with ethanol, ether.In addition to the component is isolated in extraction in wild marjoram,
It has also been found that it is naturally occurring in chenopod chenopodium ambrosiodies labiate flower thinning, the herb of shepherd's purse taro and canella cubeb litsen tree etc. are planted
In thing.Due to simple to P-cymene chemical constitution, chemical synthesis can be carried out through a variety of ways.It is main in Chemical Manufacture
If by toluene and propylene also or toluene and isopropanol are synthesized to P-cymene by alkylated reaction, its product except pair
Outside P-cymene, there are o-cymene and a cymene.Spray and leaf by steam distillation from fresh Ledum palustreL .subsp .decumdens
Du's essential oil is obtained, is separated further across rectifying, has obtained the cut that its content is 93.7%62.4%.
This rehabilitation medicament constituent preferred embodiment is illustrated below：
Being fixed with hemostasis rehabilitation material in closeer fibrous layer described in embodiment 1 is：Stop blooding rehabilitation medicament, which forms such as
Under：Gallop along on horseback celery 5g, wild marjoram 1g, spinyleaf pricklyash root 6g, cactus 3g, setose thistle 2g, bletilla 3g, borneol 2-3g, mentioned component is dry
To solid, powder is ground into, adds silty toilet cream 500g, stirs into medicinal powder, used binding agent is fixed on the closeer fibrous layer
In, which has the function that hemostasis sterilization analgesia healing of wound.
Embodiment 2
It is described be fixed with closeer fibrous layer hemostasis rehabilitation material be：Stop blooding rehabilitation medicament, and medicament composition is as follows：Walk
Horse celery 7g, wild marjoram 3g, spinyleaf pricklyash root 7g, cactus 4g, setose thistle 2.5g, bletilla 4g, borneol 2.6g, is ground into powder, adds silty to avenge
Flower 1000g, stirs into medicinal powder, mentioned component is dried to obtain solid, is ground into powder, add silty toilet cream 500g, stir into
Medicinal powder, used binding agent are fixed in the closeer fibrous layer, which has hemostasis sterilization analgesia healing of wound
Effect.
Embodiment 3
It is described be fixed with closeer fibrous layer hemostasis rehabilitation material be：Stop blooding rehabilitation medicament, and medicament composition is as follows：Gallop along on horseback
Celery 9g, wild marjoram 3g, spinyleaf pricklyash root 8g, cactus 5g, setose thistle 3g, bletilla 5g, borneol 3g, is ground into powder, adds silty snowflake 500g,
Medicinal powder is stirred into, mentioned component is dried to obtain solid, is ground into powder, adds silty toilet cream 500g, stirs into medicinal powder, it is used
Binding agent is fixed in the closeer fibrous layer, which has the function that hemostasis sterilization analgesia healing of wound.
The test effect of hemostasis sterilization analgesia healing of wound to above-mentioned wrapping tourniquet is as follows：
Artificial 200 subjects are tested, each 100 including female subjects and male subject, the age is at 25-60 Sui
Between；Whole subjects are through clinical same case surgical incision patient with operation.
200, which are operated on, needs the subject of hemostasia and healing wound to be randomly divided into 1 group of 40 people of experiment, tests 2 group of 40 people, examination
3 group of 40 people is tested, compares 1 group of 40 people, compares 2 group of 40 people, every group includes female subjects and each 20 of male subject；Experiment 1
Group is using the wrapping tourniquet containing hemostasis rehabilitation material described in the embodiment of the present invention 1；Test 2 groups and use the embodiment of the present invention
The wrapping tourniquet containing hemostasis rehabilitation material described in 2；Test 3 groups and contain hemostasis health using described in the embodiment of the present invention 3
The wrapping tourniquet of multiple material；Whole subjects continuously use 2 months, separating tests after every subject continuously uses 2 months
The positive effect of group is good and the effect of control group, test group all scars heal, the phenomenon for distending pain of not suppurating.
The beneficial effects of the invention are as follows the elastic bar and closeer fiber designed on the mesh skeleton by cotton fiber material
Layer overall structure, realizes and quickly sucks blood, and mesh skeleton can be tightened by being shunk after being wrapped up again after balance of sucking blood by elastic bar,
Further conductance makes closeer fibrous layer stop blooding closer to closeer fitting and elastic compression blutpunkte successively after mesh skeleton tightening,
Due to being fixed with the Chinese herbal medicine powder particle of hemostasis sterilization analgesia healing of wound in closeer fibrous layer, which on the one hand can be with
Hemostasis blood coagulation is played, the medicine effect for treating of anti-inflammation and sterilization analgesic, the another aspect pellet design is in closeer fibrous layer so that hemostasis
Band will not shut overall structure after tightening can be with conduct air so that suppuration of rotting does not occur for wound outermost layer；Due to the hemostasis
Recuperating medicine granule material be fixedly installed in closeer fibrous layer the therefore particle will not be dissolved into blood or come off spread it is ineffective；
Make it that the absorption of blood is quick and will not be swollen due to the use of above-mentioned fibrous material, and the design of material is safe to the human body
Have no toxic side effect, in conclusion the surgical operation is quick obvious with wrapping tourniquet wrapping hemostasis, medicinal material curative effect protrudes, to wound
Mouth bactericidal antiphlogistic analgesic specific aim is good, Rehabilitation positive effect, has in medical field especially surgical operation wrapping field wide
General purposes.
Above-described embodiment is not limit the invention in any way, every to be obtained by the way of equivalent substitution or equivalent transformation
Technical solution all fall within protection scope of the present invention, some being preferable to carry out for the present invention has shown and described in described above
Example, but as previously described, it should be understood that the present invention is not limited to form disclosed herein, is not to be taken as to other embodiment
Exclusion, and can be used for various other combinations, modification and environment, and can be in the scope of the invention is set forth herein, by upper
The technology or knowledge for stating teaching or association area are modified.And changes and modifications made by those skilled in the art do not depart from this hair
Bright spirit and scope, then all should be in the protection domain of appended claims of the present invention.
Claims (8)
- A kind of 1. surgical operation wrapping tourniquet, it is characterised in that possess cotton fiber wrapping tourniquet mesh skeleton and It is described wrapping tourniquet mesh skeleton surface side of sucking blood inside or adhere to from surface to inside elastic bar and with wound phase The closeer fibroplastic closeer fibrous layer thinner by the fiber than wrapping up tourniquet mesh skeleton of patch, in closeer fibrous layer It is fixed with hemostasis rehabilitation material.
- 2. the surgical operation wrapping tourniquet according to claim 1, it is characterised in that the closeer fiber is averaged Fibre length is 0.02~4mm.
- 3. the surgical operation wrapping tourniquet according to claim 1 or 2, it is characterised in that the closeer fiber Average fiber length is 900~9000 relative to ratio, that is, draw ratio of avarage fiber diameter.
- 4. the surgical operation according to claim 2 wrapping tourniquet, it is characterised in that the closeer fiber by selected from It is made of at least one of wood fibre, polyester fiber, foamed cotton, cellulose fibre, renewable sponge, rubber cotton.
- 5. according to the surgical operation of claim 4 wrapping tourniquet, it is characterised in that the closeer fiber is in institute The adhesion amount stated on wrapping tourniquet mesh skeleton is 0.1~10g/m2.
- 6. according to any one of them surgical operation of claim 5 wrapping tourniquet, it is characterised in that the wrapping stops Blood band mesh skeleton is weaving cotton rope.
- 7. according to any one of them surgical operation of claim 3 wrapping tourniquet, it is characterised in that the wrapping stops Blood band mesh skeleton is by selected from by wood fibre, polyester fiber, foamed cotton, cellulose fibre, renewable sponge, rubber cotton and poly- second At least one of group of enol composition and formed.
- 8. any one of them surgical operation according to claim 3 wrapping tourniquet, it is characterised in that the closeer fiber Layer includes at least one kind in gallop along on horseback celery, bletilla, cactus containing hemostasis rehabilitation material.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201711469692.4A CN107951527A (en) | 2017-12-29 | 2017-12-29 | A kind of surgical operation wrapping tourniquet |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201711469692.4A CN107951527A (en) | 2017-12-29 | 2017-12-29 | A kind of surgical operation wrapping tourniquet |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN107951527A true CN107951527A (en) | 2018-04-24 |
Family
ID=61957088
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201711469692.4A Withdrawn CN107951527A (en) | 2017-12-29 | 2017-12-29 | A kind of surgical operation wrapping tourniquet |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN107951527A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110201209A (en) * | 2018-07-27 | 2019-09-06 | 武汉纺织大学 | A kind of preparation method of porous material enhancing bletilla striata dressing |
Citations (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN201441414U (en) * | 2009-06-25 | 2010-04-28 | 王绪友 | Multi-arris tourniquet |
| CN201612657U (en) * | 2010-02-08 | 2010-10-27 | 何庆云 | Disposable medical blood pressure cuff |
| CN201664320U (en) * | 2009-07-02 | 2010-12-08 | 王沙平 | Disposable tourniquet |
| CN201675982U (en) * | 2010-05-19 | 2010-12-22 | 牟宗玲 | Novel vein ligation band |
| CN202207175U (en) * | 2011-09-20 | 2012-05-02 | 王莹 | Tourniquet convenient to connect |
| CN103393953A (en) * | 2013-08-18 | 2013-11-20 | 郑宏伟 | Traditional Chinese medicine ointment for promoting postoperative wound healing, and preparation method thereof |
| CN104013450A (en) * | 2014-06-12 | 2014-09-03 | 张家港保税区冠祥贸易有限公司 | Tourniquet bandage |
| CN104994929A (en) * | 2013-02-12 | 2015-10-21 | 新东工业株式会社 | Dust collector filter cloth |
| CN206597040U (en) * | 2016-07-20 | 2017-10-31 | 杜媛媛 | Vein compression apparatus |
-
2017
- 2017-12-29 CN CN201711469692.4A patent/CN107951527A/en not_active Withdrawn
Patent Citations (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN201441414U (en) * | 2009-06-25 | 2010-04-28 | 王绪友 | Multi-arris tourniquet |
| CN201664320U (en) * | 2009-07-02 | 2010-12-08 | 王沙平 | Disposable tourniquet |
| CN201612657U (en) * | 2010-02-08 | 2010-10-27 | 何庆云 | Disposable medical blood pressure cuff |
| CN201675982U (en) * | 2010-05-19 | 2010-12-22 | 牟宗玲 | Novel vein ligation band |
| CN202207175U (en) * | 2011-09-20 | 2012-05-02 | 王莹 | Tourniquet convenient to connect |
| CN104994929A (en) * | 2013-02-12 | 2015-10-21 | 新东工业株式会社 | Dust collector filter cloth |
| CN103393953A (en) * | 2013-08-18 | 2013-11-20 | 郑宏伟 | Traditional Chinese medicine ointment for promoting postoperative wound healing, and preparation method thereof |
| CN104013450A (en) * | 2014-06-12 | 2014-09-03 | 张家港保税区冠祥贸易有限公司 | Tourniquet bandage |
| CN206597040U (en) * | 2016-07-20 | 2017-10-31 | 杜媛媛 | Vein compression apparatus |
Non-Patent Citations (2)
| Title |
|---|
| 仲伟婷: "对聚伞花素抗炎作用的研究", 《中国优秀硕士学位论文全文数据库农业科技辑》 * |
| 苏晓莉: "走马芹杀虫活性物质提取工艺和有效成分的研究", 《中国优秀硕士学位论文全文数据库农业科技辑》 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110201209A (en) * | 2018-07-27 | 2019-09-06 | 武汉纺织大学 | A kind of preparation method of porous material enhancing bletilla striata dressing |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN206214465U (en) | Skin or surface of a wound combine dressing and its external member | |
| JP4974015B2 (en) | Brain mental stabilization material with fir tree extract | |
| RU2750286C2 (en) | Composition for local application stimulating wound healing | |
| RU2508133C2 (en) | Local delivery system comprising two aerosol chambers | |
| Aggarwal et al. | Essential oils as novel human skin penetration enhancer for transdermal drug delivery: a review | |
| JP4424628B2 (en) | Antioxidant composition for scavenging free radicals, pharmaceutical composition containing the composition, and method for producing the same | |
| WO2009031153A2 (en) | Pomegranate-derived products for the treatment of skin sores and lesions | |
| CN102274493B (en) | Bleeding-stopping, inflammation-diminishing and pain-relieving nano emulsion for use in minimally invasive beauty treatment therapy and preparation method thereof | |
| WO2005065732A1 (en) | Wound dressing and rapid wound dressing comprising a vasoconstrictive ingredient | |
| CN103610609A (en) | Chinese herbal floral water and preparation method thereof | |
| US20190060220A1 (en) | Process and Method to Accelerate Cellular Regeneration, Healing and Wound Management | |
| CN107951527A (en) | A kind of surgical operation wrapping tourniquet | |
| DE102004038285A1 (en) | Use of ethereal oils containing a polymer matrix for the production of drug delivery systems for the transdermal and/or by inhalation application of ethereal oils in aroma therapy | |
| CA3186619A1 (en) | Advanced dressing containing a polycaprolactone porous membrane | |
| CN108938490A (en) | A kind of mosquito-expelling and antipruritic wet tissue and preparation method thereof | |
| US9421235B2 (en) | Medicine containing extracts of Ficus microcarpa for healing wounds of a diabetic patient | |
| WO2008055107A2 (en) | Use of cotinus coggygria extract treating hemorrhoids | |
| CN101579423A (en) | Medicament composition for treating beriberi and preparation method thereof | |
| US20210236422A1 (en) | Nasal spray formulation having epistaxis prevention properties | |
| KR100561271B1 (en) | Herbal high concentration liquid substance based on wormwood and its spray / aerosol container processed product | |
| KR102218296B1 (en) | Sanitary pad with enhanced antibacterial and deodorizing functions and manufacturing method thereof | |
| CN104138499B (en) | A kind of Chinese medicine composition, its preparation method and its application for treating tinea of feet and hands and onychomycosis | |
| JPH11209294A (en) | Parasympathomimetic agent containing essential oil as active ingredient | |
| EP3173066A1 (en) | Plaster comprising antiedematous substances for the treatment of bruising and injury | |
| TWM610166U (en) | Microcapsule structure |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WW01 | Invention patent application withdrawn after publication |
Application publication date: 20180424 |
|
| WW01 | Invention patent application withdrawn after publication |